The Top Biosimilars News for the Week of July 2, 2018

Catch up on the week’s top rheumatology, gastroenterology, clinical practice, regulatory, policy, and business news from the world of biosimilars.

Catch up on the week’s top rheumatology, gastroenterology, clinical practice, regulatory, policy, and business news from the world of biosimilars.

Related Content:

RegulatoryPracticeBusinessPolicyRheumatologyGastroenterology
Subcutaneous Infliximab CT-P13 Superior to Placebo as Maintenance Therapy for IBD
Breaking Down Biosimilar Barriers: Interchangeability
Breaking Down Biosimilar Barriers: Payer and PBM Policies